InflaRx ends its Phase 3 trial of vilobelimab in pyoderma gangrenosum and shifts focus to INF904 amid efforts to extend its ...

The man kept getting worse; in fact, he seemed to deteriorate before their eyes. Initially, he received supplemental oxygen ...

InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.

After a poor showing of its COVID med vilobelimab in a rare skin disorder trial, German drugmaker InflaRx is going back to ...

Flexible Bronchoscopy is a non-invasive test that visualises the airways and lung interior through a flexible tube.

Regional Trends Shaping the Idiopathic Pulmonary Fibrosis Management Industry: North America leads with innovation, while Asia-Pacific shows rapid diagnostic adoption and rising treatment demand.” — ...

As the planet heats up, the concern surrounding the spread of infectious fungi, causing deaths of millions a year, is growing ...

Remdesivir was associated with a significant survival benefit and reduced risk for rehospitalization among inpatients with COVID-19 infection.

Little Aayat Fatima of Nursery had a blast as she played the hunter in an animal dance. As she and her friends grooved on ...

An alarming new study, which found homes inhabitable due to the hazard has risen by over 100 per cent, has also revealed ...

Molbreevi – a new inhaled formulation of the well-established and off-patent white blood cell stimulator molgramostim – is ...

Hogweed plants, known as Britain’s most dangerous, were spotted last week by a local resident on Cartmel Crescent and Firwood ...